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Objectives: Carotid artery angioplasty and stenting (CAS) is now routinely performed with embolic protection devices, yet
little is known about the compositional characteristics of the captured embolic debris and whether the type or quantity of
debris correlates with patient, lesion, or operator characteristics. This study examined the embolic debris generated during
CAS using electron microscopy and energy dispersive spectroscopy (EDS) for symptomatic and asymptomatic patients.
Methods: Between 2003 and 2005, CAS for carotid stenosis was performed in 175 patients. Cerebral protection devices
were used in all but three cases. Sixty-four consecutive unselected microporous filters from procedures performed by a
single vascular surgeon were obtained for analysis. Captured particulate debris within the protection devices was
quantified (number and mean size of particles) by light microscopy for all filters. Twenty protection devices (9
symptomatic, 11 asymptomatic patients) were processed for electron microscopy and EDS to assess morphology, cellular
composition, and calcium content of debris.
Results: Captured particulate matter was present in 49 filters (77%) and included particles measuring 200 to 500 m in
72%, 500 to 1000 m in 53%, and>1000 m in 33%. The mean number of captured particles was 6.9, and mean size was
248 150m.Univariate analysis revealed that sequential patient cohort and filter type were correlated with the number
(but not size) of captured particles. The number of particles significantly decreased after the first cohort of 20 patients
(11.5 particles) compared with the second (5.0 particles, P  .023) and third (5.2 particles, P  .029) cohorts. The type
of captured debris ranged from sheets of damaged red blood cells without other components to clumps of recently
activated platelets with early fibrin crosslinking to plaque debris coated with well-organized coalescing areas of platelet
thrombus. Platelet activation was more common in symptomatic patients (78%) than asymptomatic patients (27%; P <
.05). Despite the presence of calcified lesions in six patients whose filters were analyzed by EDS, <1% of energy emission
on EDS of scanned particulate debris fell within the emission range of calcium, indicating the presence of minimal calcium
in the embolic particles.
Conclusions: Particulate embolic debris is released in most patients during CAS and can measure >1000 m in one third
of patients. The number of particles may decrease with increasing operator experience with CAS. Debris captured during
CAS with embolic protection exhibits a range of cellular and acellular components on electron microscopy, with a higher
prevalence of platelet activation evident in symptomatic patients. ( J Vasc Surg 2007;45:716-25.)
Clinical Relevance:This research represents the examination of the debris products generated during carotid stenting and
captured in embolic protection filters. The size, amount, and composition of the debris has been examined and correlated
with preoperative patient, lesion, and operator characteristics. Although release of debris during these procedures is likely
a ubiquitous occurrence, the nature and amount of debris may vary substantially with different patient subgroups. A
greater understanding of the debris generated during angioplasty and stenting, as well as the characteristics of those
patients who generate the most debris, may lead to improved treatment methods and outcomes.Stroke remains a major cause of morbidity and mortality
worldwide, and up to 25% of ischemic strokes are believed to
result from hemodynamically significant stenoses of the ca-
rotid artery.1 Treatment of carotid stenosis is directed at
prevention of embolic events originating from the diseased
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716vessel. Carotid endarterectomy (CEA) has been established as
a highly effective therapy to prevent cerebrovascular events in
patients with significant carotid stenoses.2,3 However, carotid
angioplasty and stenting (CAS) has undergone considerable
evolution over the last decade and has become established as
an alternative to CEA, particularly in high-risk patients.4-8 A
major component of this evolution has been the development
of cerebral embolic protection devices. Currently, all major
carotid stenting trials and registries include the use of embolic
protection.9-11
Studies have documented several significant differences
between symptomatic and asymptomatic patients with carotid
stenosis. Most important, symptomatic patients undergoing
carotid interventions have been shown to be at increased risk
of periprocedural neurologic events compared with asymp-
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utable to the carotid plaque itself. Several groups have shown
differing characteristics between the histologic and ultrasono-
graphic appearance of atherosclerotic plaques found in symp-
tomatic and asymptomatic patients.13,14
Patients with preoperative symptoms are more likely to
showhemorrhage into the carotid plaque at time ofCEA than
those without symptoms, thus exposing intraluminal blood
flow to the prothrombotic elements below the intima.13
Symptomatic patients have also demonstrated increased
plaque necrosis and echolucency with decreased calcification
on duplex ultrasonography compared with those without
preoperative symptoms.14 These data suggest that these pa-
tients represent two distinct groups from a pathophysiologic
standpoint, and lesion characteristics of eachmay dictate their
propensity for generating emboli and thus stroke potential.
Conversely, the embolic debris captured in cerebral
protection devices may reflect the differences seen in the
atheromatous plaque found in these patients. Retrieval of
embolic protection devices postoperatively allows the ex-
amination of the debris and investigation of these theories.
The ultimate goal of these studies includes the develop-
ment of targeted strategies for the reduction of neurologic
events through increased understanding of the atheroscle-
rotic plaque and the debris generated during carotid angio-
plasty and stenting.
This study therefore sought to characterize the nature
of the embolic debris generated during CAS in terms of
quantity and content. The particulate matter captured by
embolic filter devices was examined using light microscopy,
scanning and transmission electronmicroscopy, and energy
dispersive spectroscopy (EDS) to determine the compo-
nents contained within the debris and to correlate these
findings with preoperative patient or lesion characteristics.
METHODS
Subjects. Patient demographics, comorbidities, peripro-
cedural details, complications, and outcomes were prospec-
tively accumulated on 175 consecutive patients undergoing
CAS between February 2003 and November 2005. The
indication for CAS included carotid stenosis documented
by preoperative duplex ultrasonography (peak systolic ve-
locity 230, ratio 4), magnetic resonance angiography,
or angiogram of 70%, as well as the presence of factors
considered predictive of increased risk of complications
with CEA. These risk factors included prior ipsilateral CEA,
history of cervical radiation, contralateral occlusion, or
prohibitive medical comorbidities.
Procedural details, devices, and antiplatelet therapy.
CAS was performed in the operating room angiography
suite under fixed fluoroscopic equipment (Siemens AG,
Munich, Germany) by vascular surgeons. Local anesthesia
without sedation was used in all patients.
The procedure was performed through femoral access
using systemic anticoagulation with 100 U/kg of intrave-
nous heparin upon confirmation of a hemodynamically
significant stenosis. The common carotid artery was then
cannulated and a sheath was placed just proximal to thelesion in the common carotid. Cerebral angiography was
performed before filter deployment.
Embolic protection devices were used in all but three
patients. These included the EPI FilterWire (Boston Scien-
tific, Natick, Mass), PercuSurge Balloon Occlusion device
(Medtronic, Minneapolis, Minn), Accunet (Guidant, Min-
neapolis, Minn), and Angioguard (Cordis, Somerville, NJ).
All patients were treated with self-expanding stents, includ-
ing the Wallstent (Boston Scientific), NexStent (EndoTex,
Cupertino, Calif), Acculink (Guidant), AVE (Medtronic),
and Precise (Cordis).
The choice of embolic protection device and stent was
dictated by anatomic considerations or by the clinical trial in
which the patient was enrolled. Analysis by 2 showed no
relationship between filter type and symptom status (Table I).
The three patients who were treated without embolic protec-
tion devices had restenotic lesions and internal carotid anato-
mies that precluded safe placement of the device.
Predilation of the lesion after embolic protection device
placement was performed with a 4-mm 40-mmmonorail
angioplasty balloon (Long VIVA, Boston Scientific). This
was followed by deployment of the stent and postdilation
with a 5-mm  20-mm to 6-mm  20-mm noncompliant
angioplasty balloon (Gazelle, Boston Scientific). Embolic
protection devices were then retrieved, and final cerebral
angiography was performed.
In addition to maintaining an activated clotting time of
250 seconds with heparin intraoperatively, all patients
received preoperative antiplatelet therapy. This consisted of
clopidogrel (75 mg/day) initiated 5 days before the proce-
dure or, in some patients, a single 450-mg loading dose of
clopidogrel at4 hours before initiation of the procedure.
Patients continued taking clopidogrel (75 mg/day) for 30
days postoperatively.
Postoperative follow-up visits were scheduled for each
patient at 30 days, and then every 3 months thereafter.
These visits included carotid duplex surveillance of the
treated vessel and neurologic examination. Neurologic ex-
amination was also performed by the neurology service
Table I. Frequency of different types of embolic








EPI FilterWire 9 (14.1) 12 (18.7) .05*
Accunet 8 (12.5) 22 (34.4)
Angioguard 3 (4.7) 10 (15.6)
Filters analyzed by
EM (n  20)
EPI FilterWire 3 (15) 2 (10) .05*
Accunet 4 (20) 4 (20)
Angioguard 2 (10) 5 (25)
EM, Electron microscopy.
*Not significant.after each procedure, and any deficits were documented.
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ter the procedure, the cerebral protection filters and asso-
ciated contents for 64 consecutive patients were retrieved.
These filters were unselected. A single surgeon (P.L.F.)
performed the CAS on these 64 patients. The characteris-
tics of this patient subset were examined and compared
with the other 111 patients whose filters were not retrieved
t o assure homogeneity between these two groups (Table II).
To minimize the occurrence of in-situ thrombosis with
the filters, all patients were kept systemically anticoagulated.
The recovered filters were processed by wiping the external
surface of the filter with sterile gauze, rinsing the filter with
saline, and blotting the filter dry with a sponge before fixation
in 10% neutral buffered formalin solution for 24 hours.
Photomicroscopy of the filters inmultiple axes was then
performed and the images were imported as JPEG files into
Photoshop (Adobe Corp, San Jose, Calif) for quantitative
analysis. The total number of particles and length of each
individual particle was assessed for each filter and recorded
using a video image analyzer. Particle size was represented
by length along the longest axis because most of the parti-
cles had an irregular shape. Patients with a history of
radiation or restenosis after CEA were excluded from par-
ticle size and number analysis so that only data from ath-
erosclerotic plaques was represented.
Filter analysis by scanning electron microscopy and
energy dispersive spectroscopy. Scanning and transmis-
sion electron microscopy was used to further evaluate 20
embolic protection devices (11 asymptomatic, 9 symptom-
Table II. Presence of preoperative neurologic symptoms,
comorbidities, surgical risk factors, and degree of stenosis





collected* (n  60)
Asymptomatic 126 (72) 44 (73)
Symptomatic 49 (28) 16 (27)
Hemiparesis 24 3
Amaurosis 14 4
Recent CVA 11 9
Hypertension 152 (87) 53 (88)
Hypercholesterolemia 110 (63) 43 (72)
Coronary disease 107 (61) 36 (60)
Prior cardiac bypass 44 (25) 16 (27)
Congestive heart failure 40 (23) 9 (15)
Prior myocardial infarction 43 (25) 11 (18)
Diabetes 48 (28) 19 (32)
Chronic renal insufficiency 20 (11) 6 (10)
Hemodialysis 1 (0.6) 0 (0.0)
Tobacco use 102 (58) 33 (55)
Neck irradiation 8 (4) 2 (3)
Ipsilateral CEA 26 (15) 11 (18)
Contralateral occlusion 20 (11) 5 (8)
Percent stenosis 86%  10% 86%  7%
CVA, Cerebrovascular accident; CEA, carotid endarterectomy.
*P values for the data were not significant. Categoric data expressed as n (%)
and continuous data as mean  standard deviation.atic). These 20 filters represented all filters that had suffi-cient material for sectioning and processing for the trans-
mission electron microscopy component of this analysis.
These patients were statistically indistinguishable from the
remaining 44 patients whose filters contained insufficient
material for transmission electron microscopy analysis in
terms of degree of stenosis, symptom status, and filter used
(P  .05, NS).
After quantitative analysis by light microscopy, the
filters were fixed with glutaraldehyde, followed by 1% os-
mium tetroxide, and washed with phosphate-buffered sa-
line. The nitinol struts supporting the polyurethane filter
membranes were removed, and the membranes were flat-
tened. They were then dehydrated with graded steps of
100% ethanol through liquid carbon dioxide and critically
point dried with liquid carbon dioxide. Specimens were
sputter-coated with gold-palladium for scanning electron
microscopy and EDS.
Specimens were examined under a scanning electron
microscope (Hitachi S530, Tokyo, Japan) equipped with
an x-ray detection system. The entire membrane for each
filter was inspected at low magnification, and any region
containing debris was photographed at high magnification
for further analysis by the pathologist.
Compositional analysis by EDS at 15 kVwas performed
using the scanning electron microscope equipped with an
x-ray detector (Evex, Princeton, NJ) and a nanoanalysis soft-
ware package (Evex). All regions with sufficient debris to
undergo further processing underwent compositional analysis
by transmission electron microscopy. For this analysis, filters
were processed by dehydration in 100% ethanol, followed by
fixation with glutaraldehyde and osmium tetroxide, and then
dehydrated in graded steps of ethanol through propylene
oxide. The filters were embedded in EPON (Resolution Per-
formance Products, Houston, Tex) and 1-mplastic sections
were cut and stained with methylene blue and azure II.
Multiple ultrathin sections were then taken from each piece of
embedded debris from the filters. These sections were stained
with uranyl acetate and lead citrate and viewed with a Hitachi
7000 TEM (Hitachi, Tokyo, Japan).
All scanning and transmission electron microscopic
images were assessed by an electronmicroscope pathologist
(R. G.), who was blinded to patient or treatment charac-
teristics. Presence or absence of platelet activation was
determined according to previously describedmorphologic
Table III. Morphologic changes indicative of platelet
activation on electron microscopy
Activation
state Morphologic characteristics
Inactivated Round-shaped or disc-shaped morphology
Absence of pseudopods
No spreading or coalescence
Activated Spiculation and pseudopod extension
Flattening or spreading of platelet
Coalescence and loss of distinct platelet membrane
Table adapted from Barbucci R, et al (2002)27 and Ko TM, et al (1999)25.criteria (Table III).25-27 Cell types were also identified.
d devi
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tively entered into our divisional carotid database and ana-
lyzed using SPSS software (SPSS, Chicago, Ill). Variables
were expressed as mean  standard deviation and com-
pared using the Fisher exact t test for continuous variables
and 2 analysis for nominal variables. Statistical significance
was defined as P  .05.
RESULTS
Patient and lesion characteristics. During the study
period, 175 patients underwent CAS. Included in this
group were 126 asymptomatic patients (72%) and 49 symp-
tomatic patients (28%). The high rate of asymptomatic
patients in this study was secondary to involvement in
multiple clinical trials. Distribution of symptoms in the 49
symptomatic patients included transient hemiparesis in 24,
amaurosis fugax in 14, and recent stroke in 11. Medical
comorbidities included high rates of hypertension, hyper-
cholesterolemia, and coronary artery disease (Table II). In
addition to severe medical comorbid illness, other factors
that placed patients into a high surgical risk category and
led to CAS rather than CEA included a history of neck
irradiation (4.4%), prior ipsilateral carotid CEA (14.6%),
a n d contralateral internal carotid occlusion (11.4%; Table II).
The mean preoperative degree of stenosis by duplex,
magnetic resonance angiography, or angiography was
86.2%  10.0% of distal internal carotid luminal diameter,
which correlated well with degree of stenosis demonstrated
by selective carotid angiography at time of intervention
(87.5% 9.8%). Calcification of the carotid bifurcation was
assessed by review of digital subtraction angiography and
Table IV. Presence of preoperative neurologic symptoms,
three consecutive cohorts of 20 patients
Cohort I*
n  20
Particle number 11.2  8.0








Coronary disease 13 (65)
Prior cardiac bypass 5 (25)
Congestive heart failure 4 (20)
Prior myocardial infarction 5 (25)
Diabetes 5 (25)
Chronic renal insufficiency 2 (10)
Hemodialysis 0 (0)
Tobacco use 12 (60)
Neck Irradiation 0 (0)
Ipsilateral CEA 4 (20)
Contralateral occlusion 2 (10)
Percent stenosis 89%  8%
CVA, Cerebrovascular accident; CEA, carotid endarterectomy.
*Categoric data expressed as n (%) and continuous data as mean  standarwas present in 33% (n  58).Histopathologic results. Particulate matter that was
visible without magnification was present in only 12 (19%)
of 64 retrieved filters without light microscopy; however,
morphometric analysis of debris using a stereo-dissecting
microscope revealed debris in 49 filters (77%), and only 15
filters (23%) did not have any evidence of embolic debris.
Mean number and size of captured particles was 6.9 and
248  150 m overall, and 9.5 and 309  93 m when
patients without debris were excluded. Particles measuring
200 to 500 mwere found in 72% of patients, 500 to 1000
m in 53%, and 1000 m in 33%. No differences were
found in mean particle size or number when patients were
stratified by demographics, comorbidities, or surgical risk
factors (Table IV). The mean particle size and number did
not vary by preoperative symptom status either (Fig 1).
Univariate analysis revealed that sequential patient
cohort and filter type were correlated with number of
captured particles. When stratified into three consecutive
cohorts of 20 patients each, mean size of particles did not
vary by cohort; however, the mean number of particles was
significantly higher in the first cohort of 20 patients than
the next two cohorts (11.2  8.0 vs 5.0  4.8 and 5.2 
5.0, P  .03, Fig 2). Use of the EPI FilterWire was also
associated with an increased number (but not mean size) of
captured particles compared with the PercuSurge balloon
occlusion device, the Angioguard, and the Accunet (12.8
8.2 vs 1.3  0.0, 5.4  4.9, and 6.9  5.2, respectively;
P 0.07, P 0.23, and P 0.02, respectively). Analysis of
filter type by cohort, however, revealed the EPI FilterWire
was used significantly more in the earliest cohort of patients




n  20 P
5.0  4.8 5.2  5.0 .03
216 202 NS
16 (80) 13 (65) NS




17 (85) 18 (90) NS
15 (75) 14 (70) NS
13 (65) 10 (50) NS
7 (35) 4 (20) NS
3 (15) 2 (10) NS
4 (20) 2 (10) NS
6 (30) 8 (40) NS
2 (10) 2 (10) NS
0 (0) 0 (0) NS
13 (65) 8 (40) NS
2 (10) 0 (0) NS
1 (5) 6 (30) NS
2 (10) 1 (5) NS
90%  13% 91%  5% NS
ation.com(P 0.01) and showed a trend toward increasing use of the
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quent cohorts (Fig 3).
The cohorts did not otherwise differ in age, comorbidi-
ties, preoperative symptoms, or lesion characteristics (Table
IV). When filter type and cohort were examined by multi-
variate analysis, a trend remained toward increased number
of particles in the first cohort compared with later cohorts
(mean difference of 5.2 particles, P  .17) that did not
reach statistical significance.
Electron microscopy and energy dispersive
spectroscopy. A wide range of cellular and acellular find-
ings was present on scanning electron microscopic analysis
of debris captured in embolic protection devices. The de-
bris in some filters was minimal, revealing only sheets of red
blood cells that were either normal or had evidence of only
minor shear stress injury (Fig 4, A). The most prevalent
finding in embolic debris was the presence of individual
platelets or platelet aggregates. All stages of platelet activa-
tion were represented between filters, including spiculation
and pseudopod extension, clumping and aggregation, and
eventually coalescence with loss of platelet membrane (Fig
4, B, C, and D). Platelet activation (present vs absent) was
determined for the 20 samples by the existence on electron
microscopy histopathology of one or more factors, which
are listed in Table III. Platelet activation was found to be
significantly more prevalent in symptomatic compared with
Fig 1. Mean size (a) and number (b) of embolic debris particles
stratified by presence of symptoms. Neither size nor number of
particles correlated with the presence of preoperative symptoms,
although there was a nonsignificant trend toward increased num-
ber of particles in the symptomatic group. Data are presented as
means  standard deviation.asymptomatic patients (78% vs 27%, P  .03, Fig 5).More heavily debris-laden filters had larger particu-
late matter consistent with the acellular fibrous compo-
nents of the atherosclerotic plaque, which were fre-
Fig 2. Mean size (a) and number (b) of embolic debris particles
stratified by consecutive cohorts of 20 patients each. A significant
twofold reduction in number, but not size, of particles occurred
between the first cohort and the second cohort. Data are presented
as means  standard deviation.
Fig 3. Mean number of particles (a) detected according to type of
embolic filter used. The EPI Filterwire captured significantly more
particles compared with other filter types. However, figure (b)
reveals that this filter was used preferentially in the first cohort of 20
patients when more emboli were generated and less frequently in
later cohorts. Data are presented as means  standard deviation.quently coated with coalescing regions of platelet
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further assisted in differentiation between cell types and
other amorphous debris. Identified components in-
cluded red blood cells, polymorphonuclear leukocytes,
lymphocytes, lipid-laden macrophages, platelets, and fi-
Fig 4. Scanning electronmicroscopy of the surface of ca
sheets normal red blood cells to (B) scattered nonactiva
eventually coalesce into large areas of platelet thrombus.
Fig 5. Platelet activation as assessed by morphologic characteris-
tics on electron microscopy in symptomatic and asymptomatic
patients. Debris retrieved from symptomatic patients was more
likely to contain evidence of platelet activation than asymptomatic
patients (78% vs 27%, P  .03).brin networks (Fig 7). No specific cell type predomi-nated the inflammatory cell population nor did the pres-
ence of inflammatory cell infiltrate correlate with
preoperative symptom status.
Despite the presence of calcified lesions on angiography
in six patients (54%) whose filters were assessed by EDS,
1% of energy emission on EDS of scanned particulate
debris fell within the emission range of calcium, indicating
the absence of clinically relevant calcified emboli.
DISCUSSION
Intuitively, the use of a filter to capture particulate
debris released during CAS is an attractive idea, and this
study supports previous reports on the topic indicating that
the generation of debris is most likely a ubiquitous event
whose detection depends on the rigor with which one
examines for it. Transcranial Doppler has clearly docu-
mented the phenomenon of distal embolization in patients
undergoing CEA as well as CAS, both with and without
embolic protection devices. Debris was visible without
microscopy in 19% of embolic protection filters evaluated in
this study, and this figure ranges up to approximately
63% in other studies.16 Furthermore, the use of a stereo-
dissecting microscope reveals debris in 50% to 80% of
embolic protection devices, and this does not take into
filters revealed a variety of debris types, ranging from (A)
latelets, to (C) clumping of activated platelets that (D)rotid
ted paccount the particles small enough to pass through the filter
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arterioles and capillary beds.17-19
End-organ tissue ischemia, conversely, can be docu-
mented by the appearance of new focal ischemic defects on
postoperative brain magnetic resonance imaging in up to
43% of unselected patients undergoing CAS with or with-
out embolic protection and in up to 78% of patients with
noncalcified or echolucent plaques on duplex imaging.19-21
This study illustrates a relatively novel use of electron
microscopy for the evaluation of carotid embolic debris.
The low volume of material retrieved during CAS prohibits
Fig 6. A and B, Filter surface and pores containing larg
interlacing strands of fibrin deposition as visualized by sca
m in diameter.
Fig 7. Transmission electron microscopy allows for definitive cell
type determination and displays multiple cellular and acellular
structures, including red cells (RBC), polymorphonuclear (PMN)
cells, lymphocytes, lipid-containing phagocytic cells, and abundant
platelets and fibrin strands.study by biochemical assays and makes routine histologydifficult. Scanning and transmission electron microscopy,
however, can produce a significant amount of information
from a small amount of material, including data on the type
of cellular and acellular material contained as well as bio-
logic activity within the sample. Information gathered on
the composition of such debris can potentially be used to
develop targeted strategies to reduce the clinical ramifica-
tions of debris if not the occurrence of it.
An interesting finding was the increased incidence of
platelet activation in the debris contained within the filters
of symptomatic patients relative to asymptomatic patients.
Although the characteristics of the embolic debris or the
frequency of platelet activation can be affected by filter type
or other confounding factors, univariate analysis did not
show any differences between symptomatic and asymptom-
atic patients to filter type or any of the variables listed in
Tables II and IV.
On the contrary, only preoperative symptom status
affected frequency of platelet activation detected in the
debris, and this finding lends further credence to the notion
that symptomatic and asymptomatic patients represent two
pathophysiologically distinct groups. It is plausible that the
higher incidence of platelet activation in the symptomatic
group is a consequence of the increased plaque thrombo-
genicity noted previously by other groups13 and may even
lead to increased complication rates in these patients, al-
though this was not observed in the current study.
Although it is intuitive that plaque thrombogenicity
would be related to the number or size of debris particles,
we did not find such a relationship between these variables
and symptom status. The 50% rate of platelet activation
seen in our subgroup of 20 patients analyzed by electron
microscopy, despite preoperative loading with antiplatelet
es of embolic debris coated with clumps of platelets and
electronmicroscopy. Filter pores are approximately 100e piec
nningagents, was unexpected and suggests that a preoperative
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of platelet inhibition.
Defining a learning curve in CAS has become an im-
portant topic because of its implications for training re-
quirements and credentialing. Most of the current reports
addressing learning curves come from large single or multi-
institutional series and correlate neurologic outcomes with
center or surgeon experience.22-24 These studies are ex-
tremely important to consider when discussing such issues
as training or credentialing standards because of the ulti-
mate importance of patient outcome. In this study, univar-
iate analysis found a twofold reduction in number of emboli
generated when considering the first cohort of 20 patients
relative to the next two cohorts, suggesting the presence of
a learning curve that was overcome by the completion of
approximately 20 patients and a relationship between op-
erator experience and mean number of emboli generated.
When correcting for filter type by multivariate analysis,
a trend toward increased number of particles in the earliest
cohort persisted, but this did not retain statistical signifi-
cance. This is likely related to the small sample size, given
that each independent variable had multiple subcategories.
Although the small number of adverse neurologic events
prevented correlation with patient, operator, or lesion char-
acteristics, these data do demonstrate a potential mecha-
nism by which the technique of surgeons at an earlier point
on the learning curve may be linked to a heightened risk of
adverse neurologic events. This in turn may allow for
examination of the learning curve from a more detailed,
procedure-oriented viewpoint.
It is of interest that the number of cases required to
achieve a plateau in the mean number of emboli generated
during CAS in this study was similar to the number associ-
ated with reduced complication rates in other studies.24 To
further substantiate the presence of a learning curve by
generation of debris, future studies will have to evaluate
larger numbers of filters or concentrate on a more limited
number of filters.
CONCLUSION
The generation of microemboli during CAS is likely a
ubiquitous occurrence whose clinical ramifications may be
reduced by the use of embolic protection and adequate
antiplatelet therapy. Although neurologic outcome could
not be correlated with the size or number of embolic
particles because of the low overall rate of adverse events,
operator experience does appear to be associated with
number of emboli generated.
Electron microscopy can be effectively used to study
the components of the debris contained in microemboli,
with the intention of developing strategies directed at
reducing the clinical manifestations of these events.
Further study with larger numbers of patients will be
required to evaluate the effects of improved antiplatelet
regimens or other strategies devised as a result of the
examination of carotid embolic debris. Furthermore, cor-
relation between lesion characteristics on duplex ultra-sonography and contents of embolic filters may allow pre-
dictions regarding patients most at risk for generating
embolic debris during angioplasty and stenting.
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Dr K. Wayne Johnston (Toronto, Ontario, Canada). One of
your conclusions was the number of particles decreased as the
operator experience increased. Would you agree that actually
multivariate analysis is necessary to reach that conclusion? Specifi-
cally, perhaps you were doing more asymptomatic patients in the
latter group.
Dr Brian G. DeRubertis. When looking at those individual
cohorts, they were similar in most respects. They were, in fact,
identical in terms of their preoperative symptom status. They were
also similar in terms of their demographics and comorbidities. One
area that perhaps needs to be looked at more carefully is the topic
of filter and stent types. The stents utilized were not different
between the cohorts, but the choice of filter did differ. Multivariate
analysis may help determine the relationship between the filter
type, cohort, and number of particles. For example, the EPI
FilterWire is one in which we found a larger number of particles
than the other filters that we used; however, the FilterWire was also
more commonly used in that first cohort.We recently used another
subset of EPI FilterWires and we haven’t analyzed that data yet.
Our hope is that these filters will help us determine whether this is
a result of the type of filter used or the cohort and operator
experience.
Dr Ramon Berguer (Ann Arbor, Mich). Did you find any
correlation between the number and size of particles and the
presence or absence of silent brain infarctions in the postoperative
CT scan?
Dr DeRubertis. We did not perform routine CT scan fol-
low-up on each one of these patients. The number of particles
found during angioplasty and stenting really depends on how hard
you look for them. The detection of silent infarcts following
stenting also, to some degree, depends on how hard you look for
them. Studies have reported up to 40% of patients having newly
documented ischemic focal lesions when routine postoperative
MRI is performed. We did not have that type of MRI follow-up on
these patients. Furthermore, in terms of neurologic outcome, we
are unable to correlate any of the factors at which we looked, such
as platelet activation or number and size of particles, to outcome
because of the small number of adverse neurologic events in our
study. Out of these 175 patients there were three that had ischemic
strokes. All three of these resolved with no residual deficits, two of
them within 48 hours. Of those three patients, only two of their
filters were available for analysis, and there wasn’t any real consis-which was very large in size. The other one had a large volume of
debris and was somewhat of an outlier in terms of the number of
particles contained. Correlation of any of these findings to out-
comes or MR or CT data is not possible from this study.
DrHishamBassiouny (Chicago, Ill). As you know there is an
increased risk of ischemic events following carotid stenting in
octogenarians compared to non-octogenarians. Have you corre-
lated the quantity and character of debris with age? Secondly,
previous studies have demonstrated an association between B
mode ultrasound qualitative and quantitative plaque features phe-
nomena such as echolucency and gray-scale median analysis and
risk of stroke with carotid stenting. Do you have any data relating
such imaging criteria with the risk and the size of emboli? Finally,
I have a comment with regards to calcification and arteriography.
Arteriography is a suboptimal measure of plaque calcification. We
find that spiral CT is more precise in determining the degree of
plaque calcification and its location (ie, is it abluminal or adventi-
tial). Have you utilized spiral CT for evaluation of carotid plaque
calcification and if so does this structural variable impact the results
of your findings?
Dr DeRubertis. Roughly 13% of our patients were octoge-
narians in this study. When comparing between different age
cohorts, there were no differences in the number of particles
released from those samples that we examined. As for your second
question regarding plaque echolucency on preoperative imaging,
we did not correlate that with the number of particles released,
although it certainly could be an important factor. Some groups
have suggested that noncalcified echolucent lesions are more likely
to embolize and result in ischemic infarcts on MR. I mentioned
that up to 40% of patients who have routine postoperative MRs
done after these procedures can have new ischemic infarcts. This
number can increase to 60% to 70% of patients with “soft” or
echolucent plaques.
Dr Peter Pappas (Newark, NJ). I wanted to kind of revisit the
question Dr Bassiouny just asked you regarding the plaque mor-
phology. I was very surprised to see from your data that the
symptomatic and asymptomatic plaques both seemed to embolize
to the same degree. I was wondering if your preoperative plaque
morphology assessment enabled you to predict which asymptom-
atic plaques would embolize and which ones would remain stable.
Dr Lal from our own institution (UMDNJ-New Jersey Medical
School) has done a lot of work on this topic, as well as Dr
Bassiouny. His data seems to indicate that the plaques with the
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embolize more. In addition, these plaque characteristics predict
which asymptomatic plaques will actually become symptomatic or
may embolize more during the carotid angioplasties. So did you
get ultrasound images at all on these patients?
Dr DeRubertis. Our routine preoperative imaging is duplex
ultrasonography, sowe certainly could do that.Wehave not done that
at this point. But we do duplex every one. A minority of patients get
angiography, MRA, or CTA but our routine imaging technique is
ultrasonography. We did not stratify these patients based on their
ultrasound findings. The angiograms we used in determining the
degree of calcification were our initial DSA runs during diagnosticDr Pappas. Since you’re getting more MRAs and you’re
doing duplex perioperatively, perhaps in the next 60 patients you
can compare the two modalities and tell us if one modalaity is
better than the other.
Dr DeRubertis. Sure.
Dr Jacob Schneiderman (Tel-Hashomer, Israel). Do you
have basic ex vivo electron microscopic data regarding the analysis
of typical necrotic core content to correlate with findings related to
debris collected from the protective device filters?
Dr DeRubertis. In terms of an ex vivo analysis where we
experimentally. . .
Dr Schneiderman. Exactly.
cerebral angiography immediately prior to treatment. Dr DeRubertis. No, we didn’t do that.
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